Back
Alterity Therapeutics 10K Form
Sell
28
ATHE
Alterity Therapeutics
Last Price:
1.20
Seasonality Move:
2.19%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ATHE News And Ratings
See the #1 stock for the next 7 days that we like better than ATHE
ATHE Financial Statistics
Sales & Book Value
Annual Sales: | $99.82K |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0 |
Annual Sales: | $0.78 |
Price / Book: | 0 |
Profitability
EPS (TTM): | -0.70920 |
---|---|
Net Income (TTM): | $-11.16M |
Gross Margin: | $189.63K |
Return on Equity: | 0% |
Return on Assets: | 0% |
Alterity Therapeutics Earnings Forecast
Key Alterity Therapeutics Financial Ratios
- The Gross Profit Margin over the past 3 years for ATHE is 100.00%.
- The Selling, General & Administrative Expenses for ATHE have been equal to 2,981.41% of Gross Profit Margin.
- The Interest Expense is -0.22% of Operating Income.
- Per Share Earnings over the last 27 years have been positive in 12 years.
Alterity Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | ATHE |
CUSIP: | 02155X |
Website: | alteritytherapeutics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
ATHE Technical Analysis vs Fundamental Analysis
Sell
28
Alterity Therapeutics (ATHE)
is a Sell
Is Alterity Therapeutics a Buy or a Sell?
-
Alterity Therapeutics stock is rated a Sell
The current Alterity Therapeutics [ATHE] share price is $1.16. The Score for ATHE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.